Notice Type
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Product: Lamisil
Active Ingredient: Terbinafine hydrochloride 10mg/g equivalent to 8.8mg terbinafine
Dosage Form: Topical solution
New Zealand Sponsor: Novartis Consumer Health Australasia Pty Limited (New Zealand)
Manufacturers: Novartis Pharma AG, Basel, Switzerland
Novartis Pharma SAS, Huningue, France
Product: Solox
Active Ingredient: Lansoprazole 15mg
Dosage Form: Capsule
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Liconsa SA, Guadalajara, Spain
Dated this 30th day of July 2010.
STEWART JESSAMINE, Acting Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).